These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19444931)

  • 1. In vitro selection and efficacy of topical skin protectants against the nerve agent VX.
    Millerioux J; Cruz C; Bazire A; Lallement G; Lefeuvre L; Josse D
    Toxicol In Vitro; 2009 Apr; 23(3):539-45. PubMed ID: 19444931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds.
    Millerioux J; Cruz C; Bazire A; Polly V; Lallement G; Lefeuvre L; Josse D
    Toxicol In Vitro; 2009 Feb; 23(1):127-33. PubMed ID: 18951968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pickering emulsions for skin decontamination.
    Salerno A; Bolzinger MA; Rolland P; Chevalier Y; Josse D; Briançon S
    Toxicol In Vitro; 2016 Aug; 34():45-54. PubMed ID: 27021875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermostyx (IB1) - High efficacy and safe topical skin protectant against percutaneous toxic agents.
    Dachir S; Barness I; Fishbine E; Meshulam J; Sahar R; Eisenkraft A; Amir A; Kadar T
    Chem Biol Interact; 2017 Apr; 267():25-32. PubMed ID: 27417258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V; Cruz C; Licausi J; Bazire A; Lallement G; Boudry I
    Toxicology; 2008 Apr; 246(1):73-82. PubMed ID: 18294748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of reactive topical skin protectants against sulfur mustard and nerve agents.
    Koper O; Lucas E; Klabunde KJ
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S59-70. PubMed ID: 10594903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):35-8. PubMed ID: 15943757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
    Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX.
    Larsson A; Qvarnström J; Lindberg S; Wigenstam E; Öberg L; Afshin Sander R; Johansson S; Bucht A; Thors L
    Toxicol Lett; 2021 Mar; 339():32-38. PubMed ID: 33370593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
    Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
    Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the topical skin protectant in advanced development.
    Liu DK; Wannemacher RW; Snider TH; Hayes TL
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S40-5. PubMed ID: 10594900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human scalp permeability to the chemical warfare agent VX.
    Rolland P; Bolzinger MA; Cruz C; Briançon S; Josse D
    Toxicol In Vitro; 2011 Dec; 25(8):1974-80. PubMed ID: 21762776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSDL decontamination of human skin contaminated with the nerve agent VX.
    Thors L; Lindberg S; Johansson S; Koch B; Koch M; Hägglund L; Bucht A
    Toxicol Lett; 2017 Mar; 269():47-54. PubMed ID: 28179194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin.
    Dalton CH; Hall CA; Lydon HL; Chipman JK; Graham JS; Jenner J; Chilcott RP
    J Appl Toxicol; 2015 May; 35(5):543-50. PubMed ID: 25219755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin.
    Thors L; Koch M; Wigenstam E; Koch B; Hägglund L; Bucht A
    Chem Biol Interact; 2017 Aug; 273():82-89. PubMed ID: 28601555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of VX and sulfur mustard by enzymatic haloperoxidation.
    Amitai G; Adani R; Hershkovitz M; Bel P; Rabinovitz I; Meshulam H
    J Appl Toxicol; 2003; 23(4):225-33. PubMed ID: 12884405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A topical skin protectant against chemical warfare agents.
    Kadar T; Fishbine E; Meshulam J; Sahar R; Amir A; Barness I
    Isr Med Assoc J; 2003 Oct; 5(10):717-9. PubMed ID: 14719467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.